ArticleExperimental biology and medicine (Maywood, N.J.)2025
High-fidelity, personalized cardiac modeling via AI-driven 3D reconstruction and embedded silicone rubber printing.
Article in Experimental biology and medicine (Maywood, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence in Adult Cardiovascular Medicine and Surgery: Real-World Deployments and Outcomes.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The burgeoning clinical demand for patient-specific cardiac modeling encounters significant challenges. The current clinical cardiac models are either difficult to manufacture or lack of detailed geometric structures and hence, often fail to incorporate important patient-specific characteristics. Moreover, most 3D-printable soft materials, such as Thermoplastic Poly-Urethane (TPU) or elastic resins, exhibit insufficient flexibility and biocompatibility to accurately mimic cardiac tissues, therefore limiting their ability to truly replicate patient-specific cardiac conditions. To address these limitations, we propose an innovative method for patient-specific cardiac substructure reconstruction based on the integration of Artificial Intelligence (AI) and embedded 3D printing. First, by combining medical imaging data (CT scan) with AI-driven high-precision 3D reconstruction algorithms, the new method segments the patient-specific cardiac structure into 10 substructures. The average Dice coefficient across the ten substructures is 0.87. Second, it uses an embedded 3D printing technique which utilizes silicone rubber matrix as supporting structure and uses diluted catalyst ink to extrude onto the supporting matrix. Through precise regulation of the matrix composition, material deposition rate and curing time, it can fabricate high-fidelity, complex 3D patient-specific silicone heart models with the average dimensional error less than 0.5 mm. The proposed method can substantially reduce manual intervention and post-processing time. The fabricated models provide valuable morphological insights for cardiovascular diagnosis and treatment planning. It is believed that many clinic applications will follow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.